• 330 Citations
  • 10 h-Index
1984 …2012
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where C Simon Sebastian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Water Intoxication Medicine & Life Sciences
Drug Dose Response Relationship Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Withholding Treatment Medicine & Life Sciences
Enalapril Medicine & Life Sciences
Clozapine Medicine & Life Sciences
Placebos Medicine & Life Sciences
Schizophrenic Psychology Medicine & Life Sciences

Research Output 1984 2012

  • 330 Citations
  • 10 h-Index
  • 14 Article
  • 6 Letter
  • 3 Review article
  • 1 Comment/debate
12 Citations (Scopus)

Kinetics and metabolism of fomepizole in healthy humans

McMartin, K. E., Sebastian, C. S., Dies, D. & Jacobsen, D., Jun 1 2012, In : Clinical Toxicology. 50, 5, p. 375-383 9 p.

Research output: Contribution to journalArticle

Enzyme kinetics
Metabolism
Kinetics
fomepizole
Antidotes
Therapeutics
Aripiprazole
1 Citation (Scopus)

Aripiprazole: An appraisal of the translation of complex receptor effects into clinical outcomes

Buckley, P. F. & Sebastian, C. S., Sep 1 2005, In : Therapy. 2, 5, p. 699-707 9 p.

Research output: Contribution to journalReview article

Mood Disorders
Schizophrenia
Clinical Pharmacology
Antipsychotic Agents
Aripiprazole

Olanzapine-induced hyperprolactinemia and galactorrhea reversed with addition of bromocriptine: A case report [5]

Miller, D. E. & Sebastian, C. S., Jan 1 2005, In : Journal of Clinical Psychiatry. 66, 2, p. 269-270 2 p.

Research output: Contribution to journalLetter

olanzapine
Bromocriptine
Galactorrhea
Prolactin
Psychotic Disorders
17 Citations (Scopus)

Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia

Sebastian, C. S., Glazer, W. & Buckley, P. F., Feb 1 2004, In : Current Medicinal Chemistry. 11, 3, p. 329-342 14 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Schizophrenia
Drug therapy
Therapeutics
Placebos